Therapix Signs Exclusive License Agreement with Yissum Research Development
Therapix Biosciences Ltd., a specialty clinical-stage pharmaceutical company specializing in the development of cannabinoid-based drugs, today announced that it has signed a sublicense…
Read More...
Read More...